175 related articles for article (PubMed ID: 6226570)
1. [Medroxyprogesterone acetate. Biochemical and clinical aspects].
Ayala AR; Almazań M
Ginecol Obstet Mex; 1982 Sep; 50(305):253-9. PubMed ID: 6226570
[No Abstract] [Full Text] [Related]
2. [Experiences with Depo-Provera as a contraceptive agent].
Kollstedt E; Sjöborg G
Jordemodern; 1984; 97(1-2):18-20. PubMed ID: 6231273
[No Abstract] [Full Text] [Related]
3. Contraceptives and cancer--looking for the evidence.
Cent Afr J Med; 1992 Feb; 38(2):88-9. PubMed ID: 1387044
[No Abstract] [Full Text] [Related]
4. DMPA and bone density.
BMJ; 1991 Aug; 303(6800):467-8. PubMed ID: 1833007
[No Abstract] [Full Text] [Related]
5. Depo-provera. A lesson in communication.
Dennerstein G
Aust Fam Physician; 1988 Mar; 17(3):176-8. PubMed ID: 2965569
[No Abstract] [Full Text] [Related]
6. [Hormonal contraception using depot preparations].
Keller PJ
Ther Umsch; 1986 May; 43(5):395-9. PubMed ID: 2941890
[No Abstract] [Full Text] [Related]
7. [Effectiveness of injectable contraceptives in Mexican women].
Garza-Flores J; Rodríguez V; Cravioto MC; del Real Mora O; Anderson J; Landeros J; Díaz Sánchez V; Lichtenberg R; Pérez-Palacios G
Bol Oficina Sanit Panam; 1985 Feb; 98(2):181-6. PubMed ID: 3156612
[No Abstract] [Full Text] [Related]
8. Injectable contraception.
Mishell DR
J Reprod Med; 2002 Sep; 47(9 Suppl):777-9. PubMed ID: 12380405
[No Abstract] [Full Text] [Related]
9. [Injectable contraception using depot progestagens].
Velasco Murillo V; Correu Azcona S
Ginecol Obstet Mex; 1983 Jul; 51(315):191-7. PubMed ID: 6242048
[TBL] [Abstract][Full Text] [Related]
10. Update on Depo-Provera.
Sapire KE
S Afr Med J; 1992 May; 81(9):444-5. PubMed ID: 1533472
[No Abstract] [Full Text] [Related]
11. [Depo-Provera--antineoplastic agents which is also a contraceptive].
Tylleskär J
Jordemodern; 1988 Mar; 101(3):55-8. PubMed ID: 2967271
[No Abstract] [Full Text] [Related]
12. [Acceptability of medroxyprogesterone acetate in rural areas of Mexico].
Velasco Murillo V; Cervantes Bustamante A; Correu Azcona S; García López E
Ginecol Obstet Mex; 1981 Mar; 49(293):153-61. PubMed ID: 6459270
[TBL] [Abstract][Full Text] [Related]
13. Depot-medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
Int J Cancer; 1991 Sep; 49(2):191-5. PubMed ID: 1831803
[TBL] [Abstract][Full Text] [Related]
14. [Depot medroxyprogesterone acetate: clinical and metabolic effects (lipids, glucose, hemostasis)].
Hyjazi Y; Maes E; Hurlet A; Masure R; Vekemans M
J Gynecol Obstet Biol Reprod (Paris); 1985; 14(1):93-103. PubMed ID: 3159786
[TBL] [Abstract][Full Text] [Related]
15. [Real and false risks of injectable hormonal contraception].
Revaz C
Gynakol Rundsch; 1984; 24 Suppl 1():20-5. PubMed ID: 6240435
[No Abstract] [Full Text] [Related]
16. Safety of depot medroxyprogesterone acetate.
Bonhomme MG; Potts DM; Fortney JA; Allen MY
Lancet; 1991 Oct; 338(8772):942. PubMed ID: 1681281
[No Abstract] [Full Text] [Related]
17. Depot medroxyprogesterone and risk of breast cancer.
Gray RH
BMJ; 1989 Oct; 299(6707):1099. PubMed ID: 2531619
[No Abstract] [Full Text] [Related]
18. Progestogens for contraception.
Fraser IS
Aust Fam Physician; 1988 Oct; 17(10):882-5. PubMed ID: 2977095
[No Abstract] [Full Text] [Related]
19. Depo-Provera: the jury still out.
Gold RB
Fam Plann Perspect; 1983; 15(2):78-81. PubMed ID: 6231191
[No Abstract] [Full Text] [Related]
20. The Women's Health and Reproductive Rights Campaign on depo provera. More than just a little prick.
Health Visit; 1989 Jul; 62(7):228. PubMed ID: 2526797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
